HCAT Health Catalyst, Inc.
Nasdaq · SEC CIK 1636422 · EDGAR
- Bought, last 12 months
- $105.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $200.6K 2 sales by 2 insiders
- Filings on record
- 343 since 2021-07-06, latest 2026-09-16 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Larson-Green Julie | Dir | — | $128.2K |
| Kohl Simeon | CEO, Dir | $105.4K | — |
| Landry Benjamin | GC | — | $72.4K |
| Albert Benjamin | CEO, Dir | — | — |
| Hoggard Green Jill | Dir | — | — |
| Freeman Kevin Lee | Chief Commercial Off | — | — |
| Alger Jason | CFO | — | — |
| Burton Daniel D. | CEO, Dir | — | — |
| Gallagher Duncan | Dir | — | — |
| Llewelyn Linda | CHRO | — | — |
Transactions 414
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 16:52 | 2026-09-14 | HCAT | Kohl Simeon | CEO, Dir | A - Grant | $0.00 | +2.75M | 2.80M | +5,495% | $0 | |
| 2026-09-16 16:52 | 2026-09-14 | HCAT | Kohl Simeon | CEO, Dir | P - Purchase | $1.79 | +59.0K | 2.86M | +2% | +$105.4K | |
| 2026-09-11 16:08 | 2026-09-10 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.67 | -35.2K | 1.39M | -2% | -$59.0K | |
| 2026-09-03 17:15 | 2026-09-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +9,766 | 185.1K | +6% | $0 | |
| 2026-09-03 17:11 | 2026-09-01 | HCAT | Alger Jason | CFO | F - Tax | $1.70 | -18.0K | 704.9K | -2% | -$30.6K | |
| 2026-09-03 17:10 | 2026-09-01 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.70 | -321 | 1.42M | -0.0% | -$546.86 | |
| 2026-09-03 16:05 | 2026-09-01 | HCAT | Landry Benjamin | GC | F - Tax | $1.70 | -13.2K | 351.4K | -4% | -$22.4K | |
| 2026-07-20 17:19 | 2026-07-16 | HCAT | Hoggard Green Jill | Dir | A - Grant | $0.00 | +80.7K | 144.6K | +126% | $0 | |
| 2026-07-20 17:19 | 2026-07-16 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +80.7K | 175.3K | +85% | $0 | |
| 2026-07-20 17:19 | 2026-07-16 | HCAT | Nelson Steven H | Dir | A - Grant | $0.00 | +80.7K | 235.5K | +52% | $0 | |
| 2026-07-20 17:18 | 2026-07-16 | HCAT | Spencer Justin | Dir | A - Grant | $0.00 | +80.7K | 149.3K | +118% | $0 | |
| 2026-06-15 16:42 | 2026-06-10 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.69 | -34.5K | 1.42M | -2% | -$58.3K | |
| 2026-06-03 19:46 | 2026-06-01 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.37 | -336 | 1.46M | -0.0% | -$460.39 | |
| 2026-06-03 19:46 | 2026-06-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $1.37 | -8,519 | 321.1K | -3% | -$11.7K | |
| 2026-06-03 19:45 | 2026-06-01 | HCAT | Alger Jason | CFO | F - Tax | $1.37 | -18.8K | 722.8K | -3% | -$25.8K | |
| 2026-06-03 19:45 | 2026-06-01 | HCAT | Landry Benjamin | GC | F - Tax | $1.37 | -13.8K | 364.5K | -4% | -$18.9K | |
| 2026-06-03 19:42 | 2026-06-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +12.7K | 94.6K | +16% | $0 | |
| 2026-05-04 17:17 | 2026-05-01 | HCAT | Nelson Steven H | Dir | A - Grant | $0.00 | +154.8K | 154.8K | New | $0 | |
| 2026-05-01 16:33 | 2026-04-29 | HCAT | Albert Benjamin | CEO, Dir | A - Grant | $0.00 | +1,124 | 1.46M | +0.1% | $0 | |
| 2026-05-01 16:33 | 2026-05-01 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.34 | -310 | 1.46M | -0.0% | -$416.95 | |
| 2026-03-13 | 2026-03-10 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.85 | -70.5K | 1.46M | -5% | -$130.3K | |
| 2026-03-05 | 2026-03-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +8,361 | 81.9K | +11% | $0 | |
| 2026-03-05 | 2026-03-02 | HCAT | Landry Benjamin | GC | F - Tax | $1.66 | -20.8K | 378.3K | -5% | -$34.6K | |
| 2026-03-05 | 2026-03-02 | HCAT | Alger Jason | CFO | F - Tax | $1.66 | -27.0K | 741.6K | -4% | -$44.8K | |
| 2026-03-05 | 2026-03-02 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.66 | -4,966 | 1.53M | -0.3% | -$8,244 | |
| 2026-03-05 | 2026-03-02 | HCAT | Llewelyn Linda | CHRO | F - Tax | $1.66 | -13.8K | 329.7K | -4% | -$23.0K | |
| 2026-02-27 | 2026-02-26 | HCAT | Landry Benjamin | GC | F - Tax | $1.75 | -6,317 | 399.2K | -2% | -$11.1K | |
| M | 2026-02-27 | 2026-02-25 | HCAT | Landry Benjamin | GC | A - Grant | $0.00 | +305.5K | 389.0K | +366% | $0 |
| 2026-02-27 | 2026-02-26 | HCAT | Alger Jason | CFO | F - Tax | $1.75 | -7,522 | 768.6K | -1.0% | -$13.2K | |
| M | 2026-02-27 | 2026-02-25 | HCAT | Alger Jason | CFO | A - Grant | $0.00 | +529.7K | 776.1K | +215% | $0 |
| 2026-02-27 | 2026-02-26 | HCAT | Llewelyn Linda | CHRO | F - Tax | $1.75 | -4,471 | 343.5K | -1% | -$7,824 | |
| M | 2026-02-27 | 2026-02-25 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +204.7K | 348.0K | +143% | $0 |
| 2026-02-27 | 2026-02-26 | HCAT | Albert Benjamin | CEO, Dir | F - Tax | $1.75 | -13.3K | 1.53M | -0.9% | -$23.3K | |
| M | 2026-02-27 | 2026-02-25 | HCAT | Albert Benjamin | CEO, Dir | A - Grant | $0.00 | +968.8K | 1.55M | +168% | $0 |
| 2026-02-19 | 2026-02-17 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +7,562 | 132.0K | +6% | $0 | |
| 2025-12-09 | 2025-12-04 | HCAT | Larson-Green Julie | Dir | S - Sale | $2.67 | -48.0K | 73.6K | -39% | -$128.2K | |
| T | 2025-12-09 | 2025-12-05 | HCAT | Landry Benjamin | GC | S - Sale | $2.64 | -27.4K | 100.0K | -22% | -$72.4K |
| 2025-12-03 | 2025-12-01 | HCAT | Alger Jason | CFO | F - Tax | $2.90 | -20.6K | 246.4K | -8% | -$59.8K | |
| 2025-12-03 | 2025-12-01 | HCAT | Landry Benjamin | GC | F - Tax | $2.90 | -14.4K | 127.4K | -10% | -$41.7K | |
| 2025-12-03 | 2025-12-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +5,731 | 121.6K | +5% | $0 | |
| 2025-12-03 | 2025-12-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $2.90 | -9,762 | 143.3K | -6% | -$28.3K | |
| 2025-12-03 | 2025-12-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $2.90 | -55.7K | 1.39M | -4% | -$161.6K | |
| 2025-12-03 | 2025-12-01 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $2.90 | -16.4K | 358.7K | -4% | -$47.6K | |
| 2025-12-03 | 2025-12-01 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +6,209 | 124.5K | +5% | $0 | |
| 2025-09-26 | 2025-09-24 | HCAT | Albert Benjamin | Pres, COO | A - Grant | $0.00 | +467.0K | 577.9K | +421% | $0 | |
| T | 2025-09-09 | 2025-09-05 | HCAT | Landry Benjamin | GC | S - Sale | $3.35 | -6,175 | 141.8K | -4% | -$20.7K |
| 2025-09-05 | 2025-09-01 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +4,970 | 118.3K | +4% | $0 | |
| 2025-09-05 | 2025-09-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +4,588 | 115.8K | +4% | $0 | |
| 2025-09-04 | 2025-09-02 | HCAT | Llewelyn Linda | CHRO | F - Tax | $3.36 | -2,854 | 153.0K | -2% | -$9,589 | |
| 2025-09-04 | 2025-09-02 | HCAT | Alger Jason | CFO | F - Tax | $3.36 | -2,613 | 267.0K | -1.0% | -$8,780 | |
| 2025-09-04 | 2025-09-02 | HCAT | Ross David Coy | Chief Tech, Product Off | F - Tax | $3.36 | -3,360 | 204.2K | -2% | -$11.3K | |
| 2025-09-04 | 2025-09-02 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $3.36 | -4,578 | 375.1K | -1% | -$15.4K | |
| 2025-09-04 | 2025-09-02 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $3.36 | -8,335 | 1.45M | -0.6% | -$28.0K | |
| 2025-09-04 | 2025-09-02 | HCAT | LeSueur Daniel | COO | F - Tax | $3.36 | -3,663 | 198.4K | -2% | -$12.3K | |
| 2025-09-04 | 2025-09-02 | HCAT | Landry Benjamin | GC | F - Tax | $3.36 | -3,138 | 148.0K | -2% | -$10.5K | |
| 2025-09-03 | 2025-09-01 | HCAT | Spencer Justin | Dir | A - Grant | $0.00 | +68.6K | 68.6K | New | $0 | |
| 2025-07-11 | 2025-07-09 | HCAT | Smith S. Dawn | Dir | A - Grant | $0.00 | +36.2K | 101.7K | +55% | $0 | |
| 2025-07-10 | 2025-07-09 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +36.2K | 113.3K | +47% | $0 | |
| 2025-07-10 | 2025-07-09 | HCAT | Hoggard Green Jill | Dir | A - Grant | $0.00 | +36.2K | 63.9K | +131% | $0 | |
| 2025-07-10 | 2025-07-09 | HCAT | KANE JOHN A | Dir | A - Grant | $0.00 | +36.2K | 170.7K | +27% | $0 | |
| 2025-07-10 | 2025-07-09 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +36.2K | 111.3K | +48% | $0 | |
| T | 2025-06-09 | 2025-06-05 | HCAT | Landry Benjamin | GC | S - Sale | $3.94 | -6,057 | 151.1K | -4% | -$23.9K |
| 2025-06-03 | 2025-06-02 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $3.63 | -8,658 | 1.46M | -0.6% | -$31.4K | |
| 2025-06-03 | 2025-06-02 | HCAT | LeSueur Daniel | COO | F - Tax | $3.63 | -3,802 | 202.0K | -2% | -$13.8K | |
| 2025-06-03 | 2025-06-02 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $3.63 | -4,747 | 379.7K | -1% | -$17.2K | |
| 2025-06-03 | 2025-06-02 | HCAT | Alger Jason | CFO | F - Tax | $3.63 | -2,712 | 269.6K | -1.0% | -$9,845 | |
| 2025-06-03 | 2025-06-02 | HCAT | Llewelyn Linda | CHRO | F - Tax | $3.63 | -2,965 | 155.9K | -2% | -$10.8K | |
| 2025-06-03 | 2025-06-02 | HCAT | Landry Benjamin | GC | F - Tax | $3.63 | -3,255 | 157.2K | -2% | -$11.8K | |
| 2025-06-03 | 2025-06-01 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +4,080 | 77.1K | +6% | $0 | |
| 2025-06-03 | 2025-06-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +3,766 | 75.0K | +5% | $0 | |
| T | 2025-05-07 | 2025-05-05 | HCAT | LeSueur Daniel | COO | S - Sale | $4.10 | -5,209 | 205.8K | -2% | -$21.4K |
| T | 2025-04-07 | 2025-04-03 | HCAT | LeSueur Daniel | COO | S - Sale | $4.15 | -5,209 | 211.0K | -2% | -$21.6K |
| T | 2025-03-10 | 2025-03-06 | HCAT | Landry Benjamin | GC | S - Sale | $4.55 | -13.8K | 160.4K | -8% | -$62.9K |
| T | 2025-03-10 | 2025-03-05 | HCAT | LeSueur Daniel | COO | S - Sale | $4.52 | -16.9K | 216.2K | -7% | -$76.4K |
| 2025-03-04 | 2025-03-03 | HCAT | Landry Benjamin | GC | F - Tax | $4.58 | -9,024 | 174.3K | -5% | -$41.3K | |
| 2025-03-04 | 2025-03-03 | HCAT | Alger Jason | CFO | F - Tax | $4.58 | -7,304 | 272.4K | -3% | -$33.5K | |
| 2025-03-04 | 2025-03-03 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $4.58 | -33.7K | 1.47M | -2% | -$154.2K | |
| 2025-03-04 | 2025-03-01 | HCAT | Gallagher Duncan | Dir | A - Grant | $0.00 | +3,033 | 73.0K | +4% | $0 | |
| 2025-03-04 | 2025-03-03 | HCAT | Freeman Kevin Lee | Chief Commercial Off | F - Tax | $4.58 | -10.8K | 384.4K | -3% | -$49.5K | |
| 2025-03-04 | 2025-03-03 | HCAT | LeSueur Daniel | COO | F - Tax | $4.58 | -9,232 | 233.2K | -4% | -$42.3K | |
| 2025-03-04 | 2025-03-01 | HCAT | Larson-Green Julie | Dir | A - Grant | $0.00 | +2,450 | 71.3K | +4% | $0 | |
| 2025-03-04 | 2025-03-03 | HCAT | Llewelyn Linda | CHRO | F - Tax | $4.58 | -7,525 | 158.8K | -5% | -$34.5K | |
| M | 2025-02-24 | 2025-02-20 | HCAT | Alger Jason | CFO | A - Grant | $0.00 | +192.9K | 267.7K | +258% | $0 |
| M | 2025-02-24 | 2025-02-20 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +80.8K | 166.4K | +94% | $0 |
| M | 2025-02-24 | 2025-02-20 | HCAT | Burton Daniel D. | CEO, Dir | A - Grant | $0.00 | +371.4K | 1.50M | +33% | $0 |
| M | 2025-02-24 | 2025-02-20 | HCAT | Landry Benjamin | GC | A - Grant | $0.00 | +111.0K | 169.8K | +189% | $0 |
| M | 2025-02-24 | 2025-02-20 | HCAT | Freeman Kevin Lee | Chief Commercial Off | A - Grant | $0.00 | +158.3K | 376.9K | +72% | $0 |
| M | 2025-02-24 | 2025-02-20 | HCAT | LeSueur Daniel | COO | A - Grant | $0.00 | +156.3K | 242.4K | +182% | $0 |
| T | 2025-02-20 | 2025-02-18 | HCAT | Llewelyn Linda | CHRO | S - Sale | $5.43 | -6,441 | 85.8K | -7% | -$35.0K |
| T | 2025-02-06 | 2025-02-05 | HCAT | LeSueur Daniel | COO | S - Sale | $5.76 | -5,209 | 86.0K | -6% | -$30.0K |
| T | 2025-01-17 | 2025-01-15 | HCAT | Llewelyn Linda | CHRO | S - Sale | $5.80 | -6,442 | 92.3K | -7% | -$37.4K |
| T | 2025-01-10 | 2025-01-06 | HCAT | LeSueur Daniel | COO | S - Sale | $7.51 | -5,209 | 91.3K | -5% | -$39.1K |
| T | 2025-01-10 | 2025-01-06 | HCAT | Landry Benjamin | GC | S - Sale | $7.52 | -2,500 | 72.2K | -3% | -$18.8K |
| T | 2025-01-02 | 2024-12-30 | HCAT | Gallagher Duncan | Dir | S - Sale | $6.93 | -4,500 | 69.9K | -6% | -$31.2K |
| T | 2024-12-27 | 2024-12-23 | HCAT | Gallagher Duncan | Dir | S - Sale | $6.98 | -4,500 | 74.4K | -6% | -$31.4K |
| T | 2024-12-18 | 2024-12-16 | HCAT | Llewelyn Linda | CHRO | S - Sale | $7.88 | -6,442 | 98.7K | -6% | -$50.8K |
| T | 2024-12-10 | 2024-12-06 | HCAT | Alger Jason | CFO | S - Sale | $8.32 | -19.6K | 86.7K | -18% | -$163.1K |
| T | 2024-12-10 | 2024-12-06 | HCAT | Landry Benjamin | GC | S - Sale | $8.32 | -19.3K | 72.2K | -21% | -$160.3K |
| T | 2024-12-06 | 2024-12-04 | HCAT | LeSueur Daniel | COO | S - Sale | $7.70 | -22.8K | 96.5K | -19% | -$175.4K |
| 2024-12-04 | 2024-12-01 | HCAT | Hoggard Green Jill | Dir | A - Grant | $0.00 | +27.7K | 27.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations